Login to Your Account



EXTREME RED TAPE, WITH AN EXCEPTION: INNOVATIVE DRUGS

Beijing loosens its grip on drug prices, allows market forces to take greater role

By Shannon Ellis
Staff Writer

Wednesday, April 30, 2014

SHANGHAI – Authorities in Beijing are loosening price controls for a select number of commonly used, low-cost medicines. While few innovative drugs are expected to be affected, the move signals the government is willing to take a step back when necessary in its ongoing efforts to rein in drug costs.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription